GB1424571A - 3,4-dihydrocarbostyril derivatives their preparation and pharmaceutical compositions thereof - Google Patents

3,4-dihydrocarbostyril derivatives their preparation and pharmaceutical compositions thereof

Info

Publication number
GB1424571A
GB1424571A GB325173A GB325173A GB1424571A GB 1424571 A GB1424571 A GB 1424571A GB 325173 A GB325173 A GB 325173A GB 325173 A GB325173 A GB 325173A GB 1424571 A GB1424571 A GB 1424571A
Authority
GB
United Kingdom
Prior art keywords
formula
group
iii
compound
hydrogen
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
GB325173A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Otsuka Pharmaceutical Co Ltd
Original Assignee
Otsuka Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from JP47092558A external-priority patent/JPS5241268B2/ja
Priority claimed from JP9255772A external-priority patent/JPS5324431B2/ja
Priority claimed from JP47092560A external-priority patent/JPS5246231B2/ja
Application filed by Otsuka Pharmaceutical Co Ltd filed Critical Otsuka Pharmaceutical Co Ltd
Publication of GB1424571A publication Critical patent/GB1424571A/en
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/20—Oxygen atoms
    • C07D215/22—Oxygen atoms attached in position 2 or 4
    • C07D215/227—Oxygen atoms attached in position 2 or 4 only one oxygen atom which is attached in position 2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/20—Oxygen atoms
    • C07D215/24—Oxygen atoms attached in position 8
    • C07D215/26—Alcohols; Ethers thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Quinoline Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
GB325173A 1972-04-13 1973-01-22 3,4-dihydrocarbostyril derivatives their preparation and pharmaceutical compositions thereof Expired GB1424571A (en)

Applications Claiming Priority (8)

Application Number Priority Date Filing Date Title
JP47037182A JPS48103590A (da) 1972-04-13 1972-04-13
JP47037181A JPS517672B2 (da) 1972-04-13 1972-04-13
JP47092558A JPS5241268B2 (da) 1972-09-14 1972-09-14
JP9255772A JPS5324431B2 (da) 1972-09-14 1972-09-14
JP47092560A JPS5246231B2 (da) 1972-09-14 1972-09-14
JP47120953A JPS5229745B2 (da) 1972-04-13 1972-12-02
JP47125858A JPS5239036B2 (da) 1972-04-13 1972-12-14
JP47128972A JPS5241269B2 (da) 1972-04-13 1972-12-21

Publications (1)

Publication Number Publication Date
GB1424571A true GB1424571A (en) 1976-02-11

Family

ID=27572212

Family Applications (2)

Application Number Title Priority Date Filing Date
GB325173A Expired GB1424571A (en) 1972-04-13 1973-01-22 3,4-dihydrocarbostyril derivatives their preparation and pharmaceutical compositions thereof
GB3417075A Expired GB1424572A (en) 1972-04-13 1973-01-22 3,4-dihydrocarbostyril derivatives and their preparation

Family Applications After (1)

Application Number Title Priority Date Filing Date
GB3417075A Expired GB1424572A (en) 1972-04-13 1973-01-22 3,4-dihydrocarbostyril derivatives and their preparation

Country Status (17)

Country Link
JP (5) JPS48103590A (da)
AR (1) AR209575A1 (da)
AU (1) AU475964B2 (da)
BE (1) BE794669A (da)
CA (1) CA1025447A (da)
CH (1) CH575929A5 (da)
DD (2) DD112446A5 (da)
DE (1) DE2302027C2 (da)
DK (1) DK141603B (da)
FI (1) FI53703C (da)
FR (1) FR2179715B1 (da)
GB (2) GB1424571A (da)
HK (1) HK19481A (da)
NL (1) NL158176B (da)
NO (1) NO140589C (da)
SE (1) SE380018B (da)
YU (1) YU41187B (da)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0005828A1 (de) * 1978-06-06 1979-12-12 Hoechst Aktiengesellschaft Neue substituierte Phenylpiperazinderivate, diese enthaltende Arzneimittel und Verfahren zu deren Herstellung
EP0006506A1 (de) * 1978-06-23 1980-01-09 Roche Diagnostics GmbH 1,2-Dihydro-chinolin-2-on-Derivate, Verfahren zu deren Herstellung sowie diese Verbindungen enthaltende Arzneimittel
US5053514A (en) * 1988-08-10 1991-10-01 Otsuka Pharmaceutical Company, Limited Cardiotonics
US5266577A (en) * 1988-08-10 1993-11-30 Otsuka Pharmaceutical Company Ltd. Method of treating congestive heart failure using carbostyril derivatives

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5082218A (da) * 1973-11-10 1975-07-03
US4022784A (en) * 1974-01-31 1977-05-10 Otsuka Pharmaceutical Company Limited 5-[1-Hydroxy-2-(substituted-amino)]alkyl-8-substituted-carbostyril and -3,4-dihydrocarbostyril derivatives
US4137331A (en) 1974-06-19 1979-01-30 Sandoz Ltd. 3-Piperidino-2-hydroxypropoxy substituted-2-indolinones
JPS516971A (en) * 1974-07-08 1976-01-20 Otsuka Pharma Co Ltd Nitoro 3*44 jihidorokarubosuchirirujudotaino seizoho
JPS5129486A (en) * 1974-09-02 1976-03-12 Otsuka Pharma Co Ltd * 33 arukiruamino 22 hidorokishi * purohokishi 3 44 jihidorokarubosuchirirujudotai no seizoho
JPS5148674A (en) * 1974-10-17 1976-04-26 Otsuka Pharma Co Ltd 3 44 jihidorokarubosuchirirujudotaino seizoho
JPS5152178A (ja) * 1974-10-31 1976-05-08 Otsuka Pharma Co Ltd Karubosuchirirujudotaino seizoho
JPS5152179A (ja) * 1974-10-31 1976-05-08 Otsuka Pharma Co Ltd Karubosuchirirujudotaino seizoho
JPS5152180A (ja) * 1974-10-31 1976-05-08 Otsuka Pharma Co Ltd Karubosuchirirujudotaino seizoho
FI58329C (fi) * 1974-11-08 1981-01-12 Otsuka Pharma Co Ltd Foerfarande foer framstaellning av i 8-staellning substituerade 5-(3'-alkylamino-2'-hydroxi)propoxi-3,4-dihydrokarbostyrilderivat
US4081447A (en) * 1975-04-09 1978-03-28 Abbott Laboratories 5-[2-Hydroxy-3-(3,4-dimethoxy phenethylamino)]-propoxy-3,4-dihydro carbostyril and pharmaceutically acceptable salts thereof
CH619453A5 (da) * 1976-03-17 1980-09-30 Otsuka Pharma Co Ltd
GB1574665A (en) * 1976-05-08 1980-09-10 Otsuka Pharma Co Ltd 3,4-dihydrocarbostyril derivatives and process for preparing the same
US4146630A (en) * 1976-11-12 1979-03-27 Boehringer Mannheim Gmbh Blood pressure lowering and adrenergic β-receptor inhibiting 3-(4-phenoxymethylpiperidino)-propyl-phenyl ethers
JPS54130587A (en) * 1978-03-30 1979-10-09 Otsuka Pharmaceut Co Ltd Carbostyryl derivative
AU518814B2 (en) * 1979-01-30 1981-10-22 Otsuka Pharamaceutical Co. Glaucoma treatment
DE3034237A1 (de) * 1979-09-18 1981-04-16 Otsuka Pharmaceutical Co. Ltd., Tokyo Carbostyrilderivate, verfahren zu ihrer herstellung und diese verbindungen enthaltende, antihistaminisch wirkende mittel
JPS56122356A (en) * 1980-02-29 1981-09-25 Otsuka Pharmaceut Co Ltd Carbostyril derivative
JPS58103343A (ja) * 1981-12-15 1983-06-20 Ota Seiyaku Kk プロパノ−ルアミン化合物の製造法
JPS597186A (ja) * 1982-07-02 1984-01-14 Ota Seiyaku Kk １，３，２−ジオキサチオラン２−オキシド誘導体
JPS63193086U (da) * 1987-05-30 1988-12-13
DE3808136A1 (de) * 1988-03-11 1989-09-21 Thomae Gmbh Dr K Arzneimittel, enthaltend chinolin-2,5-dione, neue chinolin-2,5-dione und verfahren zu ihrer herstellung
CA2093633A1 (en) * 1991-08-23 1993-02-24 Seiji Sato Carbostyril derivative and platelets aggregation inhibitory agent
ES2048108B1 (es) * 1992-07-17 1994-10-01 Lusochimica Spa Procedimiento para la preparacion de 5-(3-terc-butilamino-2-hidroxipropoxi)-3,4-dihidrocarboestirilo.
IT1264816B1 (it) * 1993-07-28 1996-10-10 Pergam Srl Procedimento per la preparazione di derivati del procedimento per la preparazione di derivati del 3,4-diidrocarbostirile 3,4-diidrocarbostirile
CZ300351B6 (cs) * 2005-05-26 2009-04-29 Zentiva, A. S. Zpusob prípravy 7-hydroxy-3,4-dihydrokarbostyrilu

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1058822A (en) * 1963-07-30 1967-02-15 Ici Ltd 3-amino-2-hydroxypropoxy heterocyclic derivatives
CH514611A (de) * 1968-07-05 1971-10-31 Cassella Farbwerke Mainkur Ag Verfahren zur Herstellung von Derivaten des 2-Oxo-1,2-dihydro-chinolins

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0005828A1 (de) * 1978-06-06 1979-12-12 Hoechst Aktiengesellschaft Neue substituierte Phenylpiperazinderivate, diese enthaltende Arzneimittel und Verfahren zu deren Herstellung
EP0006506A1 (de) * 1978-06-23 1980-01-09 Roche Diagnostics GmbH 1,2-Dihydro-chinolin-2-on-Derivate, Verfahren zu deren Herstellung sowie diese Verbindungen enthaltende Arzneimittel
US5053514A (en) * 1988-08-10 1991-10-01 Otsuka Pharmaceutical Company, Limited Cardiotonics
US5266577A (en) * 1988-08-10 1993-11-30 Otsuka Pharmaceutical Company Ltd. Method of treating congestive heart failure using carbostyril derivatives
US5385914A (en) * 1988-08-10 1995-01-31 Otsuka Pharmaceutical Company, Limited Cardiotonic carbostyril agents for treating heart ailments

Also Published As

Publication number Publication date
NL7302353A (da) 1973-10-16
SE380018B (da) 1975-10-27
AU475964B2 (en) 1976-09-09
DE2302027C2 (de) 1983-03-17
NO140589B (no) 1979-06-25
DK141603B (da) 1980-05-05
NO140589C (no) 1979-10-03
YU41187B (en) 1986-12-31
JPS48103590A (da) 1973-12-25
AR209575A1 (es) 1977-05-13
CA1025447A (en) 1978-01-31
GB1424572A (en) 1976-02-11
JPS4982673A (da) 1974-08-08
FI53703C (fi) 1978-07-10
AU5438673A (en) 1974-10-17
FR2179715A1 (da) 1973-11-23
JPS5241269B2 (da) 1977-10-17
YU254979A (en) 1982-10-31
JPS4981373A (da) 1974-08-06
JPS5229745B2 (da) 1977-08-03
FR2179715B1 (da) 1976-12-03
DK141603C (da) 1980-10-06
HK19481A (en) 1981-05-22
BE794669A (fr) 1973-05-16
DD108293A5 (da) 1974-09-12
FI53703B (da) 1978-03-31
JPS48103589A (da) 1973-12-25
JPS5239036B2 (da) 1977-10-03
DE2302027A1 (de) 1973-12-06
JPS4976878A (da) 1974-07-24
JPS517672B2 (da) 1976-03-10
NL158176B (nl) 1978-10-16
CH575929A5 (da) 1976-05-31
DD112446A5 (da) 1975-04-12

Similar Documents

Publication Publication Date Title
GB1424571A (en) 3,4-dihydrocarbostyril derivatives their preparation and pharmaceutical compositions thereof
ATE102193T1 (de) Thiazolidinedionederivate.
DK490288A (da) Substituerede thiazolidindionderivater
NO990227D0 (no) Heterocykliske forbindelser som farmas°ytika
HUP0004529A2 (hu) VLA-4 által mediált leukocita adhéziót gátló szulfonilezett dipeptid-származékok, ezeket tartalmazó gyógyászati készítmények, valamint alkalmazásuk
EP0356214A3 (en) Thiazolidine dione derivatives
GB1129072A (en) Benzofuran and indole derivatives
GB1148717A (en) Phenylbenz (f)-2,5-oxazocine derivatives and homologues and pharmaceutical compositions
ES369934A1 (es) Un procedimiento de preparacion de derivados 3-alcoxi-tia- nifteno-2 - carboxamidas sustituidas.
ES390121A1 (es) Un procedimiento para la preparacion de composiciones fun- gicidas.
GB1432816A (en) Pharmaceutical antimycotic compositions medicaments and method
GB1169945A (en) Pharmaceutical Compositions containing Diphenylalkyl-amine Derivatives
SE7609586L (sv) N-alkyldifenylaminer
GB1055221A (en) Pyridobenzoxazepine derivatives
GB1425706A (en) Piperidine derivatives
KR870004038A (ko) 제초제 화합물의 제조방법
GB1445927A (en) 1,4-disubstituted piperazine derivatives and their acid addition compounds and method of producing them
GB990887A (en) Carbamic acid derivatives
ES429446A1 (es) Procedimiento para preparar derivados de aminopirrol.
ES463570A1 (es) Un procedimiento para la preparacion de nuevos compuestos triciclicos biologicamente activos
ES446132A1 (es) Un procedimiento para la preparacion de nuevos derivados de acido 2-alquil (inferior)-2 o 3-cefem-4-carboxilico.
GB1428883A (en) 1,3-benzoxazine and phenyl-alkylamine derivatives
GB1297401A (da)
GB1221389A (en) 2,4-dicyano-6-nitrobenzene derivatives
IE39853B1 (en) New n'-(aminoacylaminophenyl)-acetamidines and salts thereof their production and their medicinal use

Legal Events

Date Code Title Description
PS Patent sealed
746B Proceeding under section 46(3) patents act 1977
746B Proceeding under section 46(3) patents act 1977
PE20 Patent expired after termination of 20 years

Effective date: 19930120